Arguably the most important quality for any stock is whether or not it beats the market. If it doesn't, you'd be better off putting your money in an index fund.

Three Motley Fool contributors think healthcare stocks Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) will not only beat the market in 2024, but trounce it. Here's why.

Prosper Junior Bakiny (Eli Lilly): It's difficult to find many biotech stocks that have garnered more attention than Eli Lilly over the past year. It is a leader in the weight-loss drug market thanks to its highly popular treatment, Zepbound. Wall Street analysts have exceptionally high expectations for the drug, generically known as tirzepatide, which helped drive Eli Lilly's stock price higher. And there is more where that came from.

Continue reading

Source Fool.com